Study Explores Parental Experience with Genomic Screening
Findings from the BabyScreen+ project show that while parents appreciate receiving early health information from genomic newborn screening, the process requires sensitive communication and strong counseling support. The study underscores the need for robust support systems for families as complex genetic screening becomes more routine in neonatal care.
- The BabyScreen+ project, a pilot study in Victoria, Australia, uses whole-genome sequencing to screen for over 600 treatable, childhood-onset conditions, a significant expansion from the standard newborn screening that checks for about 25 disorders. Recruitment for the 1,000-newborn study began in August 2023, with the goal of evaluating the feasibility, cost-effectiveness, and psychosocial aspects of a larger-scale program. - In Virginia, standard newborn screening is mandatory unless a parent objects on religious grounds and checks for 35 conditions, most of which are metabolic disorders. The Virginia Department of Health and the Division of Consolidated Laboratories (DCLS) manage the program, which screens approximately 95,000 samples annually. - A primary ethical challenge in expanding genomic screening is the "therapeutic gap," where technology enables screening for disorders before effective treatments are available. This raises concerns about causing parental anxiety and the potential for a child to be diagnosed with a condition for which there is no immediate medical action. - Studies show that while parents are generally in favor of expanded screening, they desire more involvement and want to receive information during the prenatal period rather than immediately after birth. Key factors influencing their decisions include the treatability, severity, and age of onset of the potential conditions. - The expansion of genomic testing creates a greater need for pre- and post-test counseling, a role that midwives are increasingly filling. Midwives are often responsible for providing initial information, taking family histories, making referrals to specialists, and offering psychological support to families navigating complex genetic results. - Research on parental experiences reveals significant concerns about privacy, the storage of genetic data, and how results might be used in the future. Limited trust in the medical system or state-run programs can amplify these worries for some parents. - To manage the vast amount of data from whole-genome sequencing, projects like BabyScreen+ are developing automated systems for analysis and interpretation. The goal is to create a scalable process where 90-95% of screen-negative cases can be reported automatically, allowing genetic professionals to focus on complex, high-chance results.
